India, April 14 -- Jaguar Health Inc. (JAGX), a commercial-stage pharmaceutical company, announced plans to use artificial intelligence (AI) platforms for the advancement of Crofelemer in treating int... Read More
India, April 14 -- The U.S. Food and Drug Administration has reminded more than 2,200 medical product companies and researchers of the requirements to submit certain clinical trial results information... Read More
India, April 14 -- Shares of Wellgistics Health, Inc. (WGRX) are up by 25% after the company announced a new joint venture aimed at expanding access to more than 200,000 patient lives. Wellgistics He... Read More
India, April 14 -- Shares of Ligand Pharmaceuticals Incorporated (LGND) are moving up about 7 percent on Tuesday morning trading after its partner Travere Therapeutics, Inc. received approval from the... Read More
India, April 14 -- Travere Therapeutics, Inc. (TVTX) shares jumped 31.57 percent to $40.42, gaining $9.72 on Monday, after the company received U.S. Food and Drug Administration approval for FILSPARI ... Read More
Noida, April 14 -- Top sources within the Uttar Pradesh Police have revealed that the violence in Noida on April 13 was no spontaneous protest but a meticulously orchestrated conspiracy. The revelati... Read More
Mumbai, April 14 -- It was doomsday for a majority of the seeded players in the semi-finals of the GD Birla Memorial Masters Inter-Cub Badminton Tournament, hosted by Bombay Gymkhana on Monday. The t... Read More
India, April 14 -- Clearmind Medicine Inc. (CMND) has announced that CMND-100 has met the primary endpoint in its FDA-approved Phase I/IIa clinical trial for Alcohol Use Disorder, marking a key milest... Read More
Kathmandu, April 14 -- On the night of April 7, a team from the Narcotics Control Bureau opened fire in Pingalasthan, Kathmandu, while trying to arrest an Indian national, Anil Kumar Paswan. He was sh... Read More
New Delhi, April 14 -- The International Monetary Fund (IMF) on Tuesday revised India's 2026-27 economic growth forecast upwards by a notch to 6.5%, from its January estimate, as the benefits of a red... Read More